R.PR
REGISTERED-PRINCIPAL REGISTER
08/17/2021
Back to search
Official data from USPTO
MEITHEAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
50
Latest update
08/17/2021
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
03/22/2017
Registration date
08/17/2021
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/17/2021
Last transaction
08/17/2021
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/06/2017
First use in commerce
10/06/2017
Drawing code
4
Owner type
03
Owner location
Chicago, IL
Examiner
WRIGHT, LAURA
Law office
N70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Meitheal Pharmaceuticals, Inc.
Meitheal Pharmaceuticals, Inc.
Representatives
Eric R. Moran MCDONNELL BOEHNEN HULBERT & BERGHOFF LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
antibacterial pharmaceutical preparations; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of diseases of the skin and subcutaneous tissue; pharmaceutical preparations for the treatment of diseases of the digestive system; pharmaceutical preparations for the treatment of diseases of the genitourinary system; muscle relaxants; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; vitamin D analogs; pharmaceutical preparations for the treatment of endocrine diseases; anticoagulants; pharmaceutical preparations for the treatment of diseases of the circulatory system; antiemetics; pharmaceutical preparations for the treatment of nausea; pharmaceutical preparations for hormone therapy; anticholinergics; pharmaceutical preparations for use in connection with anesthesia; pharmaceutical preparations for the treatment of gastrointestinal ailments; pharmaceutical preparations for the treatment of heart rhythm disorders; vasodilators; inotropes; immunosuppressants; pharmaceutical preparations for use in connection with organ transplants; vasoconstrictors; decongestants; beta-lactamase inhibitors
Publications
History of USPTO decisions and trademark events.
50 publications found
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/16/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/15/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/29/2021
IUAF
USE AMENDMENT FILED
05/21/2021
EISU
TEAS STATEMENT OF USE RECEIVED
05/21/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/05/2021
EX5G
SOU EXTENSION 5 GRANTED
01/04/2021
EXT5
SOU EXTENSION 5 FILED
11/20/2020
EEXT
SOU TEAS EXTENSION RECEIVED
11/20/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/26/2020
EX4G
SOU EXTENSION 4 GRANTED
05/22/2020
EXT4
SOU EXTENSION 4 FILED
05/22/2020
EEXT
SOU TEAS EXTENSION RECEIVED
05/22/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/26/2019
EX3G
SOU EXTENSION 3 GRANTED
11/22/2019
EXT3
SOU EXTENSION 3 FILED
11/22/2019
EEXT
SOU TEAS EXTENSION RECEIVED
11/22/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/15/2019
EX2G
SOU EXTENSION 2 GRANTED
05/13/2019
EXT2
SOU EXTENSION 2 FILED
05/13/2019
EEXT
SOU TEAS EXTENSION RECEIVED
05/13/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/21/2018
EX1G
SOU EXTENSION 1 GRANTED
11/19/2018
EXT1
SOU EXTENSION 1 FILED
11/19/2018
EEXT
SOU TEAS EXTENSION RECEIVED
11/19/2018
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/20/2018
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/20/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/22/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/27/2018
PUBO
PUBLISHED FOR OPPOSITION
03/27/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/07/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/22/2018
DPCC
DIVISIONAL PROCESSING COMPLETE
02/06/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/06/2018
IROA
RESPONSE TO ITU OFFICE ACTION ENTERED
02/05/2018
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
02/05/2018
INCD
ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
02/02/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/02/2018
ALIE
ASSIGNED TO LIE
01/15/2018
DRRR
DIVISIONAL REQUEST RECEIVED
12/28/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/28/2017
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
12/28/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/28/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/28/2017
GNRT
NON-FINAL ACTION E-MAILED
06/28/2017
CNRT
NON-FINAL ACTION WRITTEN
06/28/2017
DOCK
ASSIGNED TO EXAMINER
06/15/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/27/2017
NWAP
NEW APPLICATION ENTERED
03/25/2017
Continuous trademark protection
Get notified about every new filing that threatens MEITHEAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.